RVA.AX Insider Trading Activity and SEC Form 4 Filings
RVA.AX insider trading summary
No open-market insider purchases or sales of REVA Medical, Inc. (RVA.AX) have been reported on SEC Form 4 in the past 12 months.
Latest RVA.AX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 11, 2019 | Robert Bernard Stockman | Director | Buy | $112 (372,218.8 @ $0.00) |
| Jun 29, 2018 | Stephen N. Oesterle | Director | Buy | $25K (16,359.6 @ $1.53) |
| Jun 29, 2018 | C Raymond Larkin Jr | Director | Buy | $30K (19,631.5 @ $1.53) |
| Jun 29, 2018 | Robert Bain Thomas | Director | Buy | $25K (16,359.6 @ $1.53) |
| Jun 29, 2018 | Robert Bernard Stockman | Director | Buy | $50K (32,719.1 @ $1.53) |
| Jun 29, 2018 | Regina E Groves | Chief Executive Officer | Buy | $15K (9,815.7 @ $1.53) |
| Jun 29, 2018 | Richard M. Kimes | Senior VP, Operations | Buy | $5K (3,271.9 @ $1.53) |
| Jun 29, 2018 | Brandi Roberts | SVP & Chief Financial Officer | Buy | $8K (4,907.9 @ $1.53) |
| Jun 14, 2018 | Robert Bain Thomas | Director | Buy | $4K (2,500 @ $1.74) |
| Jun 13, 2018 | Robert Bain Thomas | Director | Buy | $5K (2,500 @ $1.86) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.